News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
US Judge Finds Biogen, Inc. Breached Pact with Biogen (JOBS)
September 4, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Reuters -- Irish drugmaker Elan Corp PLC breached a collaboration agreement with Biogen Idec Inc for the multiple sclerosis drug Tysabri in making a deal with Johnson & Johnson, a U.S. judge ruled on Thursday.
Twitter
LinkedIn
Facebook
Email
Print
Legal
Biogen
MORE ON THIS TOPIC
Drug pricing
Trump Administration Reaches Pricing Agreements with 9 More Drugmakers
December 22, 2025
·
2 min read
·
Nick Paul Taylor
Policy
Disc Shares Slip Amid Report FDA’s Prasad is Skeptical of Bitopertin’s Efficacy
December 22, 2025
·
2 min read
·
Nick Paul Taylor
Deals
Inside the 2026 Biotech Landscape: Innovation, Investment and Global Momentum
December 18, 2025
·
1 min read
·
BioSpace Insights
Leadership
The Four Employment Agreement Questions Every Pharma Executive Must Ask
December 18, 2025
·
6 min read
·
Michael Pietrack